Ardent Health, Inc. (ARDT)
NYSE: ARDT · Real-Time Price · USD
12.67
+0.20 (1.60%)
At close: Aug 13, 2025, 4:00 PM
12.00
-0.67 (-5.29%)
Pre-market: Aug 14, 2025, 8:54 AM EDT
Ardent Health Analyst Ratings
Total Analysts
12
Consensus Rating
Buy
Price Target
$19.88
Upside
+56.91%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold Maintains $18 → $15 | Hold | Maintains | $18 → $15 | +18.39% | Aug 11, 2025 |
| Keybanc | Keybanc | Buy Maintains $24 → $20 | Buy | Maintains | $24 → $20 | +57.85% | Aug 7, 2025 |
| B of A Securities | B of A Securities | Hold → Sell Downgrades $16 → $15 | Hold → Sell | Downgrades | $16 → $15 | +15.23% | Jul 16, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $21 | Buy | Reiterates | $21 | +65.75% | May 20, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $21 | Buy | Reiterates | $21 | +65.75% | May 15, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $16 → $18 | Strong Buy | Maintains | $16 → $18 | +42.07% | May 9, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +26.28% | Apr 9, 2025 |
| Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +42.07% | Apr 9, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +73.64% | Apr 1, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +73.64% | Mar 26, 2025 |
| RBC Capital | RBC Capital | Buy Maintains $23 → $21 | Buy | Maintains | $23 → $21 | +65.75% | Mar 4, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $22 | Buy | Reiterates | $22 | +73.64% | Feb 27, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $24 → $22 | Buy | Maintains | $24 → $22 | +73.64% | Jan 21, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $22 → $21 | Strong Buy | Maintains | $22 → $21 | +65.75% | Jan 6, 2025 |
| JP Morgan | JP Morgan | Hold Initiates $20 | Hold | Initiates | $20 | +57.85% | Dec 17, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $23 | Buy | Reiterates | $23 | +81.53% | Nov 14, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.